Tumor necrosis factor-alpha-induced nitric oxide restrains the apoptotic response of anterior pituitary cells

Marianela Candolfi1, Gabriela Jaita, Verónica Zaldivar

  • 1Centro de Investigaciones en Reproducción, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina.

Neuroendocrinology
|October 12, 2004
PubMed

Insights

Tumor necrosis factor-alpha (TNF-alpha) alters nitric oxide synthase (NOS) expression in pituitary cells. While upregulating inducible NOS (iNOS), it downregulates estrogen-induced endothelial NOS (eNOS), revealing NO

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) influences anterior pituitary cell proliferation and apoptosis in an estrogen-dependent manner.
  • Nitric oxide (NO) has been shown to mediate the inhibitory effects of TNF-alpha on prolactin release.

Purpose of the Study:

  • To investigate the impact of TNF-alpha on nitric oxide synthase (NOS) activity and expression in anterior pituitary cells.
  • To elucidate the role of NO in TNF-alpha-induced apoptosis of anterior pituitary cells.

Main Methods:

  • Assessing NOS activity and expression (iNOS, eNOS, nNOS) in anterior pituitary cells from rats at different estrous cycle stages and ovariectomized (OVX) rats.
  • Utilizing 17beta-estradiol (E2) and NOS inhibitors (NAME, NMMA) to study NO's role in TNF-alpha-induced apoptosis.

Main Results:

  • TNF-alpha stimulated NOS activity and upregulated inducible NOS (iNOS) gene expression in anterior pituitary cells.
  • TNF-alpha downregulated estrogen-induced endothelial NOS (eNOS) expression, while E2 stimulated eNOS expression.
  • NOS inhibitors were required for TNF-alpha to induce apoptosis, and NO appeared to restrain TNF-alpha's proapoptotic effect.

Conclusions:

  • TNF-alpha modulates NOS expression by upregulating iNOS and downregulating E2-induced eNOS in anterior pituitary cells.
  • Endogenous NO may play a restraining role, rather than a mediating role, in TNF-alpha-induced apoptosis of anterior pituitary cells.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...